Vaccine News and Research

Latest Vaccine News and Research

Study explains confounding effects of different dosages and dosing protocols on COVID-19 vaccine efficacies

A recent study investigates the paradoxical effects of dosage and dosing interval on COVID-19 vaccine efficacy.

14 Sep 2021

Severe COVID-19 linked to increase in autoantibodies

Hospitalized COVID-19 patients are substantially more likely to harbor autoantibodies - antibodies directed at their own tissues or at substances their immune cells secrete into the blood - than people without COVID-19, according to a new study.

14 Sep 2021

UK Prime Minister sets out plan to manage Covid throughout autumn and winter

The Prime Minister has today set out the government's plan to manage Covid throughout autumn and winter.

14 Sep 2021

Health leaders issue an urgent call for vaccine equity globally and in Africa

WHO Director-General Dr Tedros Adhanom Ghebreyesus and a group of global health leaders today issued an urgent call for vaccine equity globally and in Africa in particular.

14 Sep 2021

COVID-19 booster vaccine to be offered to millions of vulnerable people from next week

Millions of vulnerable people are to be offered a COVID-19 booster vaccine from next week as the government confirms it has accepted the final advice from the independent Joint Committee on Vaccination and Immunisation (JCVI).

14 Sep 2021

Top COVID-19 concerns among unvaccinated individuals

In a new study, an international team of researchers looked into concerns fueling vaccine hesitancy.

14 Sep 2021

mRNA BNT162b2 vaccine safe in immunocompromised patients

The clinical trial showed that about 72.2% of immunocompromised patients had detectable antibodies against SARS-CoV-2.

14 Sep 2021

How effective are COVID-19 vaccines against mild and severe disease?

A new paper in the New England Journal of Medicine reports on the effectiveness of the COVID-19 vaccines in a healthcare setting.

14 Sep 2021

ICUs are filled with covid — and regret

It's a struggle for Joe Gammon to talk. Lying in his bed in the intensive care unit at Ascension Saint Thomas Hospital in Nashville, Tennessee, this month, he described himself as "naive."

14 Sep 2021

Effectiveness of mRNA-1273 against asymptomatic infection, COVID-19 diagnosis, and severe outcomes

A Moderna phase 3 trial provides evidence that the RNA-1273 vaccine is highly effective in preventing disease following infection SARS-CoV-2.

14 Sep 2021

Impact of prior SARS-CoV-2 infection and vaccine on antibody levels: Texas survey

A collaborative team, led by principal investigator Dr. Eric Boerwinkle, at The University of Texas Health Science Center at Houston, School of Public Health is conducting a survey designed to assess the frequency of antibody-positive individuals across Texas. The TEXAS Coronavirus Antibody REsponse Survey (CARES) aims to look for antibodies in the blood made in response to natural SARS-CoV-2 infection or vaccination.

14 Sep 2021

Gorillas at Atlanta Zoo have been infected by SARS-CoV-2

At Zoo Atlanta, 18 western lowland gorillas are currently receiving treatment for COVID-19 as initial and tests came back positive.

14 Sep 2021

SARS-CoV-2 infections surged in England this summer, despite high vaccine uptake

Researchers in the UK have warned that England experienced a rapid exponential increase this summer in the prevalence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) – the agent that causes coronavirus disease 2019 (COVID-19) – despite high rates of vaccination uptake.

14 Sep 2021

Artemisia plant extract prevents SARS-CoV-2 replication in vitro

A new study describes the beneficial effect of an extract of Artemisia annua when used to treat cells in culture exposed to SARS-CoV-2.

13 Sep 2021

Study identifies broadly neutralizing antibody panel against SARS-like viruses

A recent study describes 40 broadly neutralizing antibodies from two individuals with a history of COVID-19 who were recently immunized against the virus.

13 Sep 2021

Rutgers study examines link between COVID-19 and memory loss, dementia

A new Rutgers study will examine how COVID-19 is affecting individuals in a number of cognitive-related areas, including memory loss, "brain fog," and dementia.

13 Sep 2021

Research supports COVID booster vaccines for those aged 60 and over

Israeli researchers conducted an important study to determine if the Pfizer-BioNTech BNT162b2 vaccine had become less effective in preventing infection.

13 Sep 2021

New model can help find optimal strategies for vaccine deployment and social distancing

Every country in the world these days must make smart decisions about how to allocate vaccines and what sort of social distancing to mandate to combat the COVID-19 pandemic.

13 Sep 2021

MD Anderson and SNIPR BIOME join forces to advance new CRISPR-based microbiome therapeutics

The University of Texas MD Anderson Cancer Center and SNIPR BIOME today announced a strategic collaboration to advance new CRISPR-based microbiome therapeutics to reduce immune-related adverse events (irAE) in patients being treated with combined immune checkpoint inhibitors.

13 Sep 2021

Young people aged 12 to 15 in England to be offered one dose of COVID-19 vaccine

People aged 12 to 15 in England will be offered one dose of the Pfizer/BioNTech COVID-19 vaccine, following advice from the four UK Chief Medical Officers (CMOs), the Health and Social Care Secretary has announced today (Monday 13 September).

13 Sep 2021

Vaccine News and Research

Latest Vaccine News and Research

Study explains confounding effects of different dosages and dosing protocols on COVID-19 vaccine efficacies

Severe COVID-19 linked to increase in autoantibodies

UK Prime Minister sets out plan to manage Covid throughout autumn and winter

Health leaders issue an urgent call for vaccine equity globally and in Africa

COVID-19 booster vaccine to be offered to millions of vulnerable people from next week

Top COVID-19 concerns among unvaccinated individuals

mRNA BNT162b2 vaccine safe in immunocompromised patients

How effective are COVID-19 vaccines against mild and severe disease?

ICUs are filled with covid — and regret

Effectiveness of mRNA-1273 against asymptomatic infection, COVID-19 diagnosis, and severe outcomes

Impact of prior SARS-CoV-2 infection and vaccine on antibody levels: Texas survey

Gorillas at Atlanta Zoo have been infected by SARS-CoV-2

SARS-CoV-2 infections surged in England this summer, despite high vaccine uptake

Artemisia plant extract prevents SARS-CoV-2 replication in vitro

Study identifies broadly neutralizing antibody panel against SARS-like viruses

Rutgers study examines link between COVID-19 and memory loss, dementia

Research supports COVID booster vaccines for those aged 60 and over

New model can help find optimal strategies for vaccine deployment and social distancing

MD Anderson and SNIPR BIOME join forces to advance new CRISPR-based microbiome therapeutics

Young people aged 12 to 15 in England to be offered one dose of COVID-19 vaccine

Event guide: 3rd mRNA Process Development & Manufacturing Europe eBook

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Flow chemistry, AI, and NMR: A next-gen approach to scalable API production

Vaccine News and Research

Latest Vaccine News and Research

Event guide: 3rd mRNA Process Development & Manufacturing Europe eBook

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Flow chemistry, AI, and NMR: A next-gen approach to scalable API production

Newsletters you may be interested in